Browsing by Subject
Ara mostrant els elements 1-20 d 90
-
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors
(American Association for Cancer Research, 2023-09-14) -
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)
(Lippincott Williams & Wilkins, 2022-12-01) -
Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer
(Frontiers Media, 2023-02-02) -
Advances in immunotherapy for cervical cancer
(SAGE Publications, 2023-03-28) -
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas
(Nature Portfolio, 2023-03-13) -
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer
(MDPI, 2021-04-17) -
BRAF activation by metabolic stress promotes glycolysis sensitizing NRASQ61-mutated melanomas to targeted therapy
(Nature Portfolio, 2022-11-19) -
BRAFV600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors
(Oxford University Press, 2023-09-07) -
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
(American Association for Cancer Research, 2023-05-15) -
Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer
(Frontiers Media, 2021-09)